|
|
 Previous Article | Table of Contents | Next Article 
Flt3 Ligand Synergizes With Granulocyte-Macrophage Colony-Stimulating Factor or Granulocyte Colony-Stimulating Factor to Mobilize Hematopoietic Progenitor Cells Into the Peripheral Blood of Mice
Kenneth Brasel,
Hilary J. McKenna,
Keith Charrier,
Phillip J. Morrissey,
Douglas E. Williams, and
Stewart D. Lyman
From the Department of Immunobiology, Immunex Corporation, Seattle, WA.
Peripheral blood progenitor cells (PBPC) are increasingly being used in the clinic as a replacement for bone marrow (BM) in the transplantation setting. We investigated the capacity of several different growth factors, including human flt3 ligand (FL), alone and in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF ) or granulocyte colony-stimulating factor (G-CSF ), to mobilize colony forming cells (CFU) into the peripheral blood (PB) of mice. Mice were injected subcutaneously (SC) with growth factors daily for up to 10 days. Comparing the single agents, we found that FL alone was superior to GM-CSF or G-CSF in mobilizing CFU into the PB. FL synergized with both GM-CSF or G-CSF to mobilize more CFU, and in a shorter period of time, than did any single agent. Administration of FL plus G-CSF for 6 days resulted in a 1,423-fold and 2,717-fold increase of colony-forming unit-granulocyte-macrophage (CFU-GM) and colony-forming unit granulocyte, erythroid, monocyte, megakaryocyte (CFU-GEMM) in PB, respectively, when compared with control mice. We also followed the kinetics of CFU numerical changes in the BM of mice treated with growth factors. While GM-CSF and G-CSF alone had little effect on BM CFU over time, FL alone increased CFU-GM and CFU-GEMM threefold and fivefold, respectively. Addition of GM-CSF or G-CSF to FL did not increase CFU in BM over levels seen with FL alone. However, after the initial increase in BM CFU after FL plus G-CSF treatment for 3 days, BM CFU returned to control levels after 5 days treatment, and CFU-GM were significantly reduced (65%) after 7 days treatment, when compared with control mice. Finally, we found that transplantation of FL or FL plus G-CSF-mobilized PB cells protected lethally irradiated mice and resulted in long-term multilineage hematopoietic reconstitution.
Blood, Vol. 90 No. 9 (November 1), 1997:
pp. 3781-3788
© 1997 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
T. L. Papenfuss, A. P. Kithcart, N. D. Powell, M. A. McClain, I. E. Gienapp, T. M. Shawler, and C. C. Whitacre
Disease-modifying capability of murine Flt3-ligand DCs in experimental autoimmune encephalomyelitis
J. Leukoc. Biol.,
December 1, 2007;
82(6):
1510 - 1518.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Carlo-Stella, M. Di Nicola, P. Longoni, L. Cleris, C. Lavazza, R. Milani, M. Milanesi, M. Magni, V. Pace, F. Colotta, et al.
Placental Growth Factor-1 Potentiates Hematopoietic Progenitor Cell Mobilization Induced by Granulocyte Colony-Stimulating Factor in Mice and Nonhuman Primates
Stem Cells,
January 1, 2007;
25(1):
252 - 261.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Huang, M. Kucia, F. Rezzoug, J. Ratajczak, M. K. Tanner, M. Z. Ratajczak, C. L. Schanie, H. Xu, I. Fugier-Vivier, and S. T. Ildstad
Flt3-Ligand-Mobilized Peripheral Blood, but Not Flt3-Ligand-Expanded Bone Marrow, Facilitating Cells Promote Establishment of Chimerism and Tolerance
Stem Cells,
April 1, 2006;
24(4):
936 - 948.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Ulyanova, L. M. Scott, G. V. Priestley, Y. Jiang, B. Nakamoto, P. A. Koni, and T. Papayannopoulou
VCAM-1 expression in adult hematopoietic and nonhematopoietic cells is controlled by tissue-inductive signals and reflects their developmental origin
Blood,
July 1, 2005;
106(1):
86 - 94.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Fukuda, H. E. Broxmeyer, and L. M. Pelus
Flt3 ligand and the Flt3 receptor regulate hematopoietic cell migration by modulating the SDF-1{alpha}(CXCL12)/CXCR4 axis
Blood,
April 15, 2005;
105(8):
3117 - 3126.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Carlo-Stella, M. Di Nicola, R. Milani, A. Guidetti, M. Magni, M. Milanesi, P. Longoni, P. Matteucci, F. Formelli, F. Ravagnani, et al.
Use of recombinant human growth hormone (rhGH) plus recombinant human granulocyte colony-stimulating factor (rhG-CSF) for the mobilization and collection of CD34+ cells in poor mobilizers
Blood,
May 1, 2004;
103(9):
3287 - 3295.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Kataoka, J. R. McGhee, R. Kobayashi, K. Fujihashi, S. Shizukuishi, and K. Fujihashi
Nasal Flt3 Ligand cDNA Elicits CD11c+CD8+ Dendritic Cells for Enhanced Mucosal Immunity
J. Immunol.,
March 15, 2004;
172(6):
3612 - 3619.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. T. H. Coates, S. M. Barratt-Boyes, L. Zhang, V. S. Donnenberg, P. J. O'Connell, A. J. Logar, F. J. Duncan, M. Murphey-Corb, A. D. Donnenberg, A. E. Morelli, et al.
Dendritic cell subsets in blood and lymphoid tissue of rhesus monkeys and their mobilization with Flt3 ligand
Blood,
October 1, 2003;
102(7):
2513 - 2521.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Karsunky, M. Merad, A. Cozzio, I. L. Weissman, and M. G. Manz
Flt3 Ligand Regulates Dendritic Cell Development from Flt3+ Lymphoid and Myeloid-committed Progenitors to Flt3+ Dendritic Cells In Vivo
J. Exp. Med.,
July 21, 2003;
198(2):
305 - 313.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. G. King, D. Horowitz, S. B. Dillon, R. Levin, A. M. Farese, T. J. MacVittie, and L. M. Pelus
Rapid mobilization of murine hematopoietic stem cells with enhanced engraftment properties and evaluation of hematopoietic progenitor cell mobilization in rhesus monkeys by a single injection of SB-251353, a specific truncated form of the human CXC chemokine GRO{beta}
Blood,
March 15, 2001;
97(6):
1534 - 1542.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Gazitt and Q. Liu
Plasma Levels of SDF-1 and Expression of SDF-1 Receptor on CD34+ Cells in Mobilized Peripheral Blood of Non-Hodgkin's Lymphoma Patients
Stem Cells,
January 1, 2001;
19(1):
37 - 45.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
H. J. McKenna, K. L. Stocking, R. E. Miller, K. Brasel, T. De Smedt, E. Maraskovsky, C. R. Maliszewski, D. H. Lynch, J. Smith, B. Pulendran, et al.
Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells
Blood,
June 1, 2000;
95(11):
3489 - 3497.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Wang, S. E. Braun, G. Sonpavde, and K. Cornetta
Antileukemic Activity of Flt3 Ligand in Murine Leukemia
Cancer Res.,
April 1, 2000;
60(7):
1895 - 1900.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
P. K. Chakravarty, A. Alfieri, E. K. Thomas, V. Beri, K. E. Tanaka, B. Vikram, and C. Guha
Flt3-Ligand Administration after Radiation Therapy Prolongs Survival in a Murine Model of Metastatic Lung Cancer
Cancer Res.,
December 1, 1999;
59(24):
6028 - 6032.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Rosenzweig, T.J. MacVittie, D. Harper, D. Hempel, R.L. Glickman, R.P. Johnson, A.M. Farese, N. Whiting-Theobald, G.F. Linton, G. Yamasaki, et al.
Efficient and Durable Gene Marking of Hematopoietic Progenitor Cells in Nonhuman Primates After Nonablative Conditioning
Blood,
October 1, 1999;
94(7):
2271 - 2286.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Gorczynski, Z. Chen, J. Hu, Y. Kai, J. Lei, V. Ramakrishna, and R. M. Gorczynski
Evidence That an OX-2-Positive Cell Can Inhibit the Stimulation of Type 1 Cytokine Production by Bone Marrow-Derived B7-1 (and B7-2)-Positive Dendritic Cells
J. Immunol.,
January 15, 1999;
162(2):
774 - 781.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Neipp, T. Zorina, M. A. Domenick, B. G. Exner, and S. T. Ildstad
Effect of FLT3 Ligand and Granulocyte Colony-Stimulating Factor on Expansion and Mobilization of Facilitating Cells and Hematopoietic Stem Cells in Mice: Kinetics and Repopulating Potential
Blood,
November 1, 1998;
92(9):
3177 - 3188.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Gyger, E. Sahovic, M. Aslam;, D. Damiani, F. Silvestri, R. Fanin, and M. Baccarani
Randomized Trial of Autologous Filgrastim-Primed Bone Marrow Transplantation Versus Filgrastim-Mobilized Peripheral Blood Stem Cell Transplantation in Lymphoma Patients
Blood,
November 1, 1998;
92(9):
3489 - 3490.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M.L. Patchen, J. Liang, T. Vaudrain, T. Martin, D. Melican, S. Zhong, M. Stewart, and P.J. Quesenberry
Mobilization of Peripheral Blood Progenitor Cells by Betafectin(R) PGG-Glucan Alone and in Combination with Granulocyte Colony-Stimulating Factor
Stem Cells,
May 1, 1998;
16(3):
208 - 217.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
S. D. Lyman and S. E. W. Jacobsen
c-kit Ligand and Flt3 Ligand: Stem/Progenitor Cell Factors With Overlapping Yet Distinct Activities
Blood,
February 15, 1998;
91(4):
1101 - 1134.
[Full Text]
[PDF]
|
|
|
| |
